Our results suggest that activation of TGR5 by INT-777 ameliorates STZ-induced cognitive impairment by modulating apoptosis, neurogenesis, and neuronal firing, which might provide new insight into the mechanism of AD and highlight TGR5 as a novel and promising target for the prevention or treatment of AD. This evidence concerns the gene GPBAR1 and Alzheimer disease.